Acetate–FFAR2 signaling induces neutrophil-derived IL-22 to protect against colitis
In the authors' words
Short-chain fatty acids (SCFAs) produced by gut microbiota are key modulators of intestinal homeostasis and immune responses. Although their anti-inflammatory roles are well established, the mechanisms by which SCFAs-FFAR2 shapes neutrophil function and influences intestinal inflammation remain unclear. Here, we demonstrate that dietary fiber or acetate protect mice from DSS-induced colitis despite increasing neutrophil infiltration into the intestinal tissue. Importantly, neutrophils are required for the protective effects of acetate, which are also dependent on FFAR2 signaling and IL-22. Neutrophil-specific deletion of FFAR2 impairs IL-22 responses, increases epithelial damage, and exacerbates colitis, while administration of recombinant IL-22 is sufficient to restore acetate protection in this context. Analysis of human ulcerative colitis biopsies reveals increased FFAR2 + neutrophils correlating with IL-22-related gene signatures. These findings indicate that acetate–FFAR2–neutrophil–IL-22 axis modulates intestinal inflammation, revealing a metabolic mechanism that links microbiota-derived signals to mucosal protection and highlighting potential therapeutic targets for inflammatory bowel diseases.
Appeared: Thursday, November 19. Proceedings of the National Academy of Sciences. Peer-reviewed journal.